Participated · Equity · Jul 2026

Kanurra is building routing and administrative infrastructure aimed at reducing drug costs for small and midsize employers. The company was founded by Semih Gultekin after he left Aviary Health. Kanurra has attracted early demand from brokers, third-party administrators and captives and says its first customers are ready to start on the platform. It is hiring for a pharmacist to lead clinical work, operators for implementation and service, sales and go-to-market staff, and engineers. Financially, the company has raised $6.35 million in its announced seed financing to fund product development and hiring. The articles do not report revenue, user counts, or prior funding rounds.

Participated · Equity · Jul 2026

Integral provides Forward Deployed Privacy Services that embed privacy experts directly into customer data pipelines to perform entity-preserving remediation and continuous privacy risk assessment. Its methodology is grounded in peer-reviewed statistical disclosure limitation research and was initially validated in healthcare, life sciences, and health data marketplaces. Integral produces defensibility artifacts such as Expert Determinations under HIPAA or signed defensibility opinions tailored to context, enabling enterprises and data originators to commercialize or share sensitive datasets. The company supports AI labs, data platforms, vertical AI builders, and enterprises operating in regulated environments. Following a $25 million financing, Integral plans to expand its privacy engineering and statistical methodology teams, invest in linkage and continuous assessment infrastructure, and broaden go-to-market efforts across the real-world data economy.

Participated · Series A · May 2026

Solstice Health offers an AI-native platform that ingests clinical data, FDA documents and approved literature to generate grounded marketing assets and score them for likelihood of medical, legal and regulatory (MLR) approval. The company combines proprietary pharmaceutical marketing models with in-house subject-matter experts to create, review and measure digital campaigns, programmatic ads and communications for patients and healthcare providers. Customers launch campaigns 12 times faster than with traditional agencies, moving assets to MLR submission in under 48 hours and to market-ready in roughly 10 days, while producing nearly three times more high-quality content per quarter. Solstice reports reducing average MLR review rounds per asset from 3.2 to 1.2 and serves over a dozen pharmaceutical companies, including several top-20 brands across oncology, immunology and metabolic diseases. The company is headquartered in New York and plans to use its recent funding to expand go-to-market efforts, accelerate product development and grow its team.

Participated · Series A · Mar 2026

Translucent AI has built an agentic artificial-intelligence platform that unifies operational, clinical, and financial data for healthcare providers, constantly scanning for signals to reveal real-time insights and the underlying causes of financial leakage. By replacing disparate spreadsheets and delayed month-end reports, the software lets finance, clinical, and operations teams collaborate on a single, current source of truth and act before problems escalate. Early adopters include Northwestern Medicine, Duly Health and Care, Wray Community District Hospital and Clinics, and Springfield Clinic, which are using the platform to uncover multi-million-dollar productivity opportunities and cut weeks of manual reconciliation work. The company positions its product as a “financial operating system” that can help stem the wave of hospital bankruptcies and closures, especially in rural settings where margins are razor thin. Founded by former ChenMed operator Jack O’Hara, Translucent AI aims to expand nationwide, bringing real-time financial intelligence to more health systems facing mounting cost pressures. The business is backed by prominent investors such as GV, NEA, Virtue, and FPV Ventures. Following its new capital injection, management plans to accelerate product development and grow the team to meet surging demand from U.S. healthcare organizations.

Participated · Equity · Jan 2026

Gyde combines proprietary artificial-intelligence technology with a broker-first operating model to modernize how agencies serve clients across insurance, health, and wealth. Its core offerings include GydeOS, a broker-facing operating system, and Gia, an intelligent assistant that automates low-complexity tasks while elevating human expertise. The company is actively acquiring high-performing health insurance agencies in the Medicare Advantage, Employee Benefits, and Individual markets, keeping existing teams in place and aligning incentives for long-term growth. Headquartered in Austin, Texas, with offices in New York City, Gyde positions brokers as lifelong advocates by delivering more proactive, personalized, and continuous support to clients. The platform’s AI-driven automation aims to deepen broker-client relationships, improve carrier partnerships, and unlock greater lifetime value per customer. Over the coming months, Gyde plans to unveil its initial cohort of partner agencies. The company has raised $60 million to fund its launch and expansion.